U.S., Australia Move Toward Biologics Compromise With Options; Amari OK's Extension

Updated: ATLANTA – The United States and Australia are inching toward a compromise on the exclusivity period for biologic drugs that would give Trans Pacific Partnership (TPP) countries more than one option for providing an appropriate level of intellectual property (IP) protection, according to informed sources. They said this progress is increasing the chances of reaching an overall TPP deal here, although such a broader agreement is not likely to come together until Sunday at the earliest. This...